Financial reports
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
ARS
2022 FY
Annual report to shareholders
1 May 23
10-K
2022 FY
Annual report
27 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
10-Q
2022 Q1
Quarterly report
13 May 22
10-K
2021 FY
Annual report
25 Mar 22
10-Q
2021 Q3
Quarterly report
12 Nov 21
Current reports
8-K
Termination of a Material Definitive Agreement
27 Dec 23
8-K
Tender and Support Agreement
3 Oct 23
8-K
POINT Biopharma Reports Second Quarter 2023 Financial Results and Provides Business Highlights
14 Aug 23
8-K
Changes in Registrant's Certifying Accountant
3 Aug 23
8-K
Departure of Directors or Certain Officers
13 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
5 Jun 23
8-K
Entry into a Material Definitive Agreement
7 Feb 23
8-K
POINT Biopharma Prices Public Offering of Common Stock
14 Sep 22
8-K
POINT Biopharma Announces Proposed Public Offering of Common Stock
13 Sep 22
8-K
POINT Biopharma Provides Updated Efficacy and Safety Data from the Lead-In Cohort of the Phase 3 SPLASH Trial in mCRPC at ESMO Congress 2022
12 Sep 22
Registration and prospectus
15-12G
Securities registration termination
8 Jan 24
POS AM
Prospectus update (post-effective amendment)
27 Dec 23
POS AM
Prospectus update (post-effective amendment)
27 Dec 23
S-8 POS
Registration of securities for employees (post-effective amendment)
27 Dec 23
S-8 POS
Registration of securities for employees (post-effective amendment)
27 Dec 23
S-8 POS
Registration of securities for employees (post-effective amendment)
27 Dec 23
25-NSE
Exchange delisting
27 Dec 23
SC 14D9/A
Tender offer solicitation (amended)
22 Dec 23
SC TO-T/A
Third party tender offer statement (amended)
22 Dec 23
SC 14D9/A
Tender offer solicitation (amended)
18 Dec 23
Proxies
Other
EFFECT
Notice of effectiveness
3 Jan 24
EFFECT
Notice of effectiveness
3 Jan 24
EFFECT
Notice of effectiveness
12 Jul 22
EFFECT
Notice of effectiveness
8 Jul 22
EFFECT
Notice of effectiveness
29 Mar 22
EFFECT
Notice of effectiveness
6 Aug 21
CORRESP
Correspondence with SEC
3 Aug 21
UPLOAD
Letter from SEC
2 Aug 21
EFFECT
Notice of effectiveness
10 Jun 21
SEC STAFF
SEC staff action: Order
9 Jun 21